NewslettersMesenchymal Cell NewsPancreatic Cell NewsReprogramming Adipose Mesenchymal Stem Cells into Islet β-Cells for the Treatment of Canine Diabetes MellitusBy Bob - August 2, 20220320In this study, Pbx1, Rfx3, Pdx1, Ngn3, Pax4 and MafA were used to form a six-gene combination to efficiently reprogram adipose MSCs (aMSCs) into reprogrammed aMSCs-derived islet β-cells.[Stem Cell Research & Therapy]Full Article